Document 0146
 DOCN  M9550146
 TI    Clinical and immunological markers in Kenyan pulmonary tuberculosis
       patients with and without HIV-1.
 DT    9505
 AU    Kivihya-Ndugga LE; Ochola JJ; Otieno G; Muthami LN; Gathua S; Diseases
       Research Unit, Kenya Medical Research Institute,; Nairobi.
 SO    East Afr Med J. 1994 Jun;71(6):373-5. Unique Identifier : AIDSLINE
       MED/95136904
 AB    Amongst newly diagnosed pulmonary tuberculosis patients, 44% were
       co-infected with human immunodeficiency virus (HIV). Pulmonary
       tuberculosis patients with HIV-1 presented more frequently with
       lymphadenopathy and diarrhoea than those without HIV-1. Peripheral blood
       CD4+ counts were significantly lower in patients with pulmonary
       tuberculosis with HIV-1 than those with pulmonary tuberculosis alone, P
       = 0.0292. CD4+ lymphocyte counts, lymphadenopathy and BCG scar could
       serve as indicators of HIV-1 infection in pulmonary tuberculosis (PTB)
       patients.
 DE    Adult  AIDS-Related Opportunistic Infections/*BLOOD/EPIDEMIOLOGY/
       IMMUNOLOGY  Biological Markers/BLOOD  BCG Vaccine  Comorbidity
       Comparative Study  CD4 Lymphocyte Count  Female  Human  *HIV
       Seronegativity  *HIV-1  Kenya/EPIDEMIOLOGY  Male  Support, Non-U.S.
       Gov't  Tuberculosis, Pulmonary/*BLOOD/EPIDEMIOLOGY/IMMUNOLOGY  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).